Short answer
U S PHYSICAL THERAPY INC /NV (USPH) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Conference call covered results for three and six months ended June 30, 2026.
U S PHYSICAL THERAPY INC /NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Conference call covered results for three and six months ended June 30, 2026
- Transcript furnished as Exhibit 99.1, providing management commentary beyond reported financial results
- Disclosure furnished under Regulation FD, limiting Exchange Act Section 18 liability and automatic incorporation into registration statements
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $214M, up 8.5%; PT revenue $182M, up 8.4%, supported by 1.662M visits and record $107.59 revenue per visit
- Adjusted EBITDA $27.0M versus $26.9M; adjusted EPS $0.75 versus $0.81 amid medical-cost pressure and hospital rollout costs
- PT gross margin fell to 19.9% from 21.4%; self-insurance costs were approximately $3.2M higher year-to-date
- Hospital affiliations integrated 31 clinics in Q2, with 39 remaining for Q3; affiliation revenue contributed $5.6M
- Full-year adjusted EBITDA guidance reaffirmed at $102M-$106M; credit facility borrowings reached $221M with $229M revolver availability
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other U S PHYSICAL THERAPY INC /NV 8-K filings
Get the next USPH 8-K as it lands
Follow USPH for push alerts, or ask the research agent what this filing means.